Resources from the same session
Opening remarks & introduction
Presenter: All Speakers
Session: Janssen Pharmaceutica N.V. - Targeted therapy optimising the future of GU cancer care – realising the value, exploring the evidence
Resources:
Webcast
How can we balance efficacy and QoL in mHSPC treatment? Why it’s time to tailor treatments
Presenter: All Speakers
Session: Janssen Pharmaceutica N.V. - Targeted therapy optimising the future of GU cancer care – realising the value, exploring the evidence
Resources:
Webcast
Revolutionising urothelial carcinoma care: Discovering the value of targeted therapy
Presenter: Guillermo Antonio De Velasco Oria
Session: Janssen Pharmaceutica N.V. - Targeted therapy optimising the future of GU cancer care – realising the value, exploring the evidence
Resources:
Webcast
Interactive Q&A session
Presenter: All Speakers
Session: Janssen Pharmaceutica N.V. - Targeted therapy optimising the future of GU cancer care – realising the value, exploring the evidence
Resources:
Webcast
Closing remarks
Presenter: All Speakers
Session: Janssen Pharmaceutica N.V. - Targeted therapy optimising the future of GU cancer care – realising the value, exploring the evidence
Resources:
Webcast